S11-2 "2 Recognition of Adverse and No-Adverse Effects in Toxicity Studies for Pharmaceuticals"(SYMPOSIUM 11: REGULATORY SCIENCE IN TOXICOLOGY RESEARCH : INTERPRETATION OF DEFINITION AND SIGNIFICANCE OF NOAEL (NON-OBSERVED ADVERSE EFFECT LEVEL) FOR PHARMA

スポンサーリンク

概要

• 論文の詳細を見る
• 日本トキシコロジー学会の論文
• 2004-10-29

著者

• Matsuo Saburo

  Lab. Toxicol. Cour. Vet. Sci. Gradu. Sch. Agri. Biol. Sci. Osaka Pref. Univ.

関連論文

• S11-2 "2 Recognition of Adverse and No-Adverse Effects in Toxicity Studies for Pharmaceuticals"(SYMPOSIUM 11: REGULATORY SCIENCE IN TOXICOLOGY RESEARCH : INTERPRETATION OF DEFINITION AND SIGNIFICANCE OF NOAEL (NON-OBSERVED ADVERSE EFFECT LEVEL) FOR PHARMA
• P7-25 Is there caspase-9 activation in causing ER stress-induced apoptosis?(IMMUNE AND ALLERGIC SYSTEM/KIDNEYS AND URINARY EXCRETION SYSTEM/CYTOTOXICITY/OTHERS-1)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)

スポンサーリンク